To unveil biological milieus underlying low disease activity (LDA) and remission versus active systemic lupus erythematosus (SLE).
No takes yet. Share an insight, caveat, or question.
Parodis et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: